TR200201613T2 - Antitümör tesirli 2-(1H-indol-3-il)-2-okso asetamidler - Google Patents

Antitümör tesirli 2-(1H-indol-3-il)-2-okso asetamidler

Info

Publication number
TR200201613T2
TR200201613T2 TR2002/01613T TR200201613T TR200201613T2 TR 200201613 T2 TR200201613 T2 TR 200201613T2 TR 2002/01613 T TR2002/01613 T TR 2002/01613T TR 200201613 T TR200201613 T TR 200201613T TR 200201613 T2 TR200201613 T2 TR 200201613T2
Authority
TR
Turkey
Prior art keywords
acetamides
indol
oxo
antitumor effect
tumors
Prior art date
Application number
TR2002/01613T
Other languages
English (en)
Inventor
Menta Ernesto
Pescalli Nicoletta
Original Assignee
Novuspharma S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novuspharma S.P.A. filed Critical Novuspharma S.P.A.
Publication of TR200201613T2 publication Critical patent/TR200201613T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Yukaridaki formül (I)'in özellikle sert tümörler, daha ayrintili olarak da bagirsak ve akciger tümörleri karsisinda antitümör tesiri sergileyen 2-(1H-indol-3-il)-2-okso-asetamidleri olup, bu formüldeki Y oksijen veya sülfür atomu ve X,R1,R2,R3,R4, ve R5 de istem 1'de tanimlandigi gibidir.
TR2002/01613T 1999-12-23 2000-12-21 Antitümör tesirli 2-(1H-indol-3-il)-2-okso asetamidler TR200201613T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI002693A IT1315267B1 (it) 1999-12-23 1999-12-23 Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale

Publications (1)

Publication Number Publication Date
TR200201613T2 true TR200201613T2 (tr) 2002-10-21

Family

ID=11384182

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/01613T TR200201613T2 (tr) 1999-12-23 2000-12-21 Antitümör tesirli 2-(1H-indol-3-il)-2-okso asetamidler

Country Status (24)

Country Link
US (1) US6753342B2 (tr)
EP (1) EP1244652B1 (tr)
JP (1) JP2003519140A (tr)
KR (1) KR100795533B1 (tr)
CN (1) CN1250542C (tr)
AT (1) ATE302772T1 (tr)
AU (1) AU776332B2 (tr)
BR (1) BR0016553A (tr)
CA (1) CA2395205A1 (tr)
CZ (1) CZ20022170A3 (tr)
DE (1) DE60022227T2 (tr)
EA (1) EA004925B1 (tr)
ES (1) ES2246918T3 (tr)
HU (1) HUP0203524A3 (tr)
IL (2) IL150329A0 (tr)
IT (1) IT1315267B1 (tr)
MX (1) MXPA02006217A (tr)
NO (1) NO323312B1 (tr)
NZ (1) NZ519689A (tr)
PL (1) PL356541A1 (tr)
SK (1) SK285682B6 (tr)
TR (1) TR200201613T2 (tr)
WO (1) WO2001047916A1 (tr)
ZA (1) ZA200204964B (tr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59913617D1 (de) 1998-04-28 2006-08-03 Elbion Ag Indolderivate und deren Verwendung als Inhibitoren der Phosphodiesterase 4.
IT1318641B1 (it) 2000-07-25 2003-08-27 Novuspharma Spa Ammidi di acidi 2-(1h-indol-3-il)-2-oxo-acetici ad attivita'antitumorale.
DE10037310A1 (de) 2000-07-28 2002-02-07 Asta Medica Ag Neue Indolderivate und deren Verwendung als Arzneimittel
CN100513404C (zh) * 2002-07-09 2009-07-15 法斯根公司 新化合物、含该化合物的药物组合物以及该化合物的应用方法
MXPA06002853A (es) 2003-09-11 2006-06-14 Kemia Inc Inhibidores citoquina.
AU2005229522A1 (en) 2004-03-11 2005-10-13 Actelion Pharmaceuticals Ltd. Indol-1-yl-acetic acid derivatives
US7645789B2 (en) 2006-04-07 2010-01-12 Vertex Pharmaceuticals Incorporated Indole derivatives as CFTR modulators
USRE50453E1 (en) 2006-04-07 2025-06-10 Vertex Pharmaceuticals Incorporated Indole derivatives as CFTR modulators
US7776905B2 (en) 2006-04-07 2010-08-17 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US10022352B2 (en) 2006-04-07 2018-07-17 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
EP2049520A4 (en) * 2006-08-07 2011-01-05 Ironwood Pharmaceuticals Inc indole compounds
US8563573B2 (en) 2007-11-02 2013-10-22 Vertex Pharmaceuticals Incorporated Azaindole derivatives as CFTR modulators
US8802868B2 (en) 2010-03-25 2014-08-12 Vertex Pharmaceuticals Incorporated Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
CN105130948A (zh) 2010-04-22 2015-12-09 弗特克斯药品有限公司 制备环烷基甲酰胺基-吲哚化合物的方法
AR084433A1 (es) 2010-12-22 2013-05-15 Ironwood Pharmaceuticals Inc Inhibidores de la faah y composiciones farmaceuticas que los contienen
US9056851B2 (en) 2011-03-25 2015-06-16 The Research Foundation For The State University Of New York Thiolactone antibiotics
CA2878057A1 (en) 2012-07-16 2014-01-23 Rossitza Gueorguieva Alargova Pharmaceutical compositions of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof
JP6543268B2 (ja) 2014-04-15 2019-07-10 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ 嚢胞性線維症膜コンダクタンス調節因子が媒介する疾患を処置するための医薬組成物
CN115785079B (zh) * 2022-11-28 2024-02-13 沈阳药科大学 4-(1h-吲哚-5-基)氨基呋喃-2(5h)-酮类化合物及其制备和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT841924E (pt) * 1995-08-02 2003-02-28 Univ Newcastle Ventures Ltd Compostos de benzimidazolo
CO4970714A1 (es) * 1997-09-05 2000-11-07 Boehringer Mannheim Gmbh Derivados ureido y tioureido de 4-amino-2(5h)-furanonas y 4-amino-2(5h) tiofenonas como agentes antitumorales
DE19814838C2 (de) * 1998-04-02 2001-01-18 Asta Medica Ag Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung
DE59913617D1 (de) * 1998-04-28 2006-08-03 Elbion Ag Indolderivate und deren Verwendung als Inhibitoren der Phosphodiesterase 4.

Also Published As

Publication number Publication date
NZ519689A (en) 2004-02-27
IL150329A0 (en) 2002-12-01
CN1250542C (zh) 2006-04-12
KR100795533B1 (ko) 2008-01-16
DE60022227T2 (de) 2006-06-22
PL356541A1 (en) 2004-06-28
DE60022227D1 (de) 2005-09-29
HUP0203524A2 (hu) 2003-03-28
SK285682B6 (sk) 2007-06-07
EA004925B1 (ru) 2004-10-28
EA200200558A1 (ru) 2002-12-26
ATE302772T1 (de) 2005-09-15
ES2246918T3 (es) 2006-03-01
EP1244652B1 (en) 2005-08-24
AU776332B2 (en) 2004-09-02
US20030158153A1 (en) 2003-08-21
CA2395205A1 (en) 2001-07-05
CZ20022170A3 (cs) 2002-09-11
NO20022976L (no) 2002-06-20
KR20020063247A (ko) 2002-08-01
US6753342B2 (en) 2004-06-22
AU2170401A (en) 2001-07-09
SK8962002A3 (en) 2002-11-06
ITMI992693A0 (it) 1999-12-23
JP2003519140A (ja) 2003-06-17
NO20022976D0 (no) 2002-06-20
ZA200204964B (en) 2004-01-29
CN1413205A (zh) 2003-04-23
NO323312B1 (no) 2007-03-12
WO2001047916A1 (en) 2001-07-05
BR0016553A (pt) 2002-09-17
EP1244652A1 (en) 2002-10-02
HUP0203524A3 (en) 2008-01-28
IL150329A (en) 2006-07-05
MXPA02006217A (es) 2004-02-26
ITMI992693A1 (it) 2001-06-23
IT1315267B1 (it) 2003-02-03

Similar Documents

Publication Publication Date Title
DE69918422D1 (de) Phthalazinone pde iii/iv hemmer
NL350077I2 (nl) Cyprosulfamide
NO20022976L (no) 2-(1H-indol-3yl)-2-okso-acetamider med antitumoraktivitet
NO970092D0 (no) Dihydrobenzofuraner
TR199901653T2 (tr) Fitalazinonlar.
PT1193270E (pt) Pirrolobenzodiazepinas
DK1200418T3 (da) Nematodicide trifluorbutener
MXPA02009567A (es) Benzoilpirzoles y su uso como herbicidas.
NO20025590D0 (no) Fenylglycin-derivater
EE200000033A (et) Uudsed tetrasoolderivaadid
DE69821530D1 (de) Dihydrobenzifurane
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
BG101002A (bg) Заместени арилалкилтио-алкилтиопиридини и използване за борба с бактерии от рода helicobacter
DK1377574T3 (da) 6-phenylbenzonaphtyridiner
SE9903290D0 (sv) Novel compounds
TR199901386T2 (tr) Imidazopiridazinler.
ATE449066T1 (de) Biguanidderivate
BG106937A (en) Novel indole derivatives
ATE413397T1 (de) Heterosubstituierte c7-taxanacetate als antitumormittel
TR199701298T1 (tr) Tetralinler.
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
ATE213236T1 (de) Substituierte benzyloxyimino-verbindungen
ATE243698T1 (de) 1,2-dihydro-1-oxo-pyrazino(1,2-)indolederivate
ID27656A (id) Turunan azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya
TR199801366T2 (tr) Izooksasefem türevleri.